The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Augmented Senile Plaque Load in Aged Female β-Amyloid Precursor Protein-Transgenic Mice
Open accessAbstract
Transgenic mice (Tg2576) overexpressing human beta-amyloid precursor protein with the Swedish mutation (APP695SWE) develop Alzheimer's disease-like amyloid beta protein (Abeta) deposits by 8 to 10 months of age. These mice show elevated levels of Abeta40 and Abeta42, as well as an age-related increase in diffuse and compact senile plaques in the brain. Senile plaque load was quantitated in the hippocampus and neocortex of 8- to 19-month-old male and female Tg2576 mice. In all mice, plaque burden increased markedly after the age of 12 months. At 15 and 19 months of age, senile plaque load was significantly greater in females than in males; in 91 mice studied at 15 months of age, the area occupied by plaques in female Tg2576 mice was nearly three times that of males. By enzyme-linked immunosorbent assay, female mice also had more Abeta40 and Abeta42 in the brain than did males, although this difference was less pronounced than the difference in histological plaque load. These data show that senescent female Tg2576 mice deposit more amyloid in the brain than do male mice, and may provide an animal model in which the influence of sex differences on cerebral amyloid pathology can be evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also as it has been reported with other APP/PS1 transgenic mice, we observed a sex-specific effect on amyloid deposition with 5XFAD female mice developing amyloid deposits earlier compared to male littermates [27], [31], [32].”
From Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model (2011) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A similar sex-specific amyloid deposition phenotype has been previously reported with other APP transgenic mouse models (Callahan et al., 2001; Wang et al., 2003).”
From Overexpression of Low-Density Lipoprotein Receptor in the Brain Markedly Inhibits Amyloid Deposition and Increases Extracellular Aβ Clearance (2009) · cites this paper as Callahan et al., 2001
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
The efficiency of systematic sampling in stereology and its prediction*
Gundersen, H. J. G., & Jensen, E. B. V. (1987) · Journal of Microscopy · doi:10.1111/j.1365-2818.1987.tb02837.x · Cited by 3,519
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Gundersen, H. J. G., Bagger, P. V., Bendtsen, T. F., Evans, S. M., Korbo, L., Marcussen, N., Møller, A., Nielsen, K. N., Nyengaard, J. R., Pakkenberg, B., et al. (1988) · Apmis · doi:10.1111/j.1699-0463.1988.tb00954.x · Cited by 2,480
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Tang, M., Jacobs, D. M., Stern, Y., Marder, K. S., Schofield, P., Gurland, B. J., Andrews, H., & Mayeux, R. P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03356-9 · Cited by 1,647
Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L. (1992) · Nature Genetics · doi:10.1038/ng0892-345 · Cited by 1,513
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Amyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
The prevalence of dementia: A quantitative integration of the literature
Jorm, A. F., Korten, A. E., & Henderson, A. S. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02906.x · Cited by 1,301
Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease
Mulnard, R. A., Cotman, C. W., Kawas, C. H., van Dyck, C. H., Sano, M. C., Doody, R. S., Koss, E., Pfeiffer, E., Jin, S., Gamst, A., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1007 · Cited by 989
Research works printed but not linked: 2
- Hsiao, 1997, Age-related neuropathology in transgenic mice with human mutant APP, Soc Neurosci Abstr, 23, 1647
- Campbell, 1987, Alzheimer's plaques and tangles: a controlled and enhanced silver staining method, Soc Neurosci Abstr, 13, 687
Cited by
Sorted by citations
Items 101–200 of 274
Melcangi, R. C., & García‐Segura, L. M. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.06.001 · Cited by 63
Contribution of Gut Microbiota to Immunological Changes in Alzheimer’s Disease
van Olst, L., Roks, S. J. M., Kamermans, A., Verhaar, B. J. H., van der Geest, A. M., Muller, M., van der Flier, W. M., & de Vries, H. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683068 · Cited by 68
Alzheimer's Disease, Oestrogen and Mitochondria: an Ambiguous Relationship
Grimm, A., Lim, Y.-A., Mensah‐Nyagan, A. G., Götz, J., & Eckert, A. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8281-x · Cited by 67
Manji, Z., Rojas, A., Wang, W., Dingledine, R. J., Varvel, N. H., & Ganesh, T. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180678 · Cited by 65
Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease
Willuweit, A., Velden, J., Godemann, R., Manook, A., Jetzek, F., Tintrup, H., Kauselmann, G., Zevnik, B., Henriksen, G., Drzezga, A. E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007931 · Cited by 60
Hampel, H., Vergallo, A., Giorgi, F. S., Kim, S. H., Depypere, H., Graziani, M., Saidi, A., Nisticò, R., & Lista, S. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.06.001 · Cited by 68
Xi, Y., Zhang, Y., Zhou, Y., Liu, Q., Chen, X., Liu, X., Grune, T., Shi, L. S., Hou, M., & Liu, Z. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102595 · Cited by 62
Progression of Seed‐Induced A β Deposition within the Limbic Connectome
Ye, L., Hamaguchi, T., Fritschi, S. K., Eisele, Y. S., Obermüller, U., Jucker, M., & Walker, L. C. (2015) · Brain Pathology · doi:10.1111/bpa.12252 · Cited by 60
Self-citationEstrogen and Neurodegeneration
Gandy, S. (2003) · Neurochemical Research · doi:10.1023/a:1023246921127 · Cited by 59
Rauch, S. M., Huen, K. H. Y., Miller, M. C., Chaudry, H., Lau, M., Sanes, J. R., Johanson, C. E., Stopa, E. G., & Burgess, R. W. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31823b0b12 · Cited by 59
Lecanu, L., Greeson, J., & Papadopoulos, V. (2005) · Pharmacology · doi:10.1159/000088929 · Cited by 58
Ciavardelli, D., Silvestri, E., Viscovo, A. D., Bomba, M., Gregorio, D. D., Moreno, M., Ilio, C. D., Goglia, F., Canzoniero, L. M. T., & Sensi, S. L. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.68 · Cited by 58
Cuervo-Zanatta, D., Garcı́a-Mena, J., & Perez‐Cruz, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201367 · Cited by 62
Dubal, D. B., Broestl, L., & Worden, K. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-24 · Cited by 62
Gau, J., Steinhilb, M. L., Kao, T.-C., D’Amato, C. J., Gaut, J. R., Frey, K. A., & Turner, R. S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64893-6 · Cited by 56
Regulation of Caspases in the Nervous System
Troy, C. M., Akpan, N., & Jean, Y. Y. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385504-6.00007-5 · Cited by 58
Characterization of the role of metallothionein-3 in an animal model of Alzheimer’s disease
Manso, Y., Carrasco, J., Comes, G., Meloni, G., Adlard, P. A., Bush, A. I., Vašák, M., & Hidalgo, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1047-9 · Cited by 60
Sex differences in steroid levels and steroidogenesis in the nervous system: Physiopathological role
Giatti, S., Diviccaro, S., Serafini, M. M., Caruso, D., García‐Segura, L. M., Viviani, B., & Melcangi, R. C. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100804 · Cited by 60
Xu, Y. X., Zhang, Y., Zhang, J.-H., Han, K., Zhang, X., Bai, X., You, L., Yu, P., Shi, Z., Chang, Y.-Z., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.07.012 · Cited by 56
Limited impact of social isolation on Alzheimer-like symptoms in a triple transgenic mouse model.
Pietropaolo, S., Sun, Y., Li, R., Brana, C., Feldon, J., & Yee, B. K. (2009) · Behavioral Neuroscience · doi:10.1037/a0013607 · Cited by 54
Impaired behavior of female tg-ArcSwe APP mice in the IntelliCage: A longitudinal study
Codita, A., Gumucio, A., Lannfelt, L., Gellerfors, P., Winblad, B. G., Mohammed, A. H. S., & Nilsson, L. N. G. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.06.034 · Cited by 52
Segatto, M., Di Giovanni, A., Marino, M., & Pallottini, V. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24315 · Cited by 52
Oliveira, S. M., Ribeiro, C. A., Cardoso, I., & Saraiva, M. J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110488 · Cited by 53
Estrogen Therapy Fails to Alter Amyloid Deposition in the PDAPP Model of Alzheimer’s Disease
Green, P. S., Bales, K. R., Paul, S. M., & Bu, G. (2005) · Endocrinology · doi:10.1210/en.2004-1433 · Cited by 53
Gender dependent APP processing in a transgenic mouse model of Alzheimer’s disease
Schäfer, S., Wirths, O., Multhaup, G., & Bayer, T. A. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0580-9 · Cited by 52
Cañete, T., Blázquez, G., Tobeña, A., Giménez‐Llort, L., & Fernández‐Teruel, A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.11.004 · Cited by 53
Chan, J., Jones, N. C., Bush, A. I., O'Brien, T. J., & Kwan, P. (2015) · Epilepsia · doi:10.1111/epi.12993 · Cited by 52
Santiard-Baron, D., Langui, D., Delehedde, M., Delatour, B., Schombert, B., Touchet, N., Tremp, G. L., Paul, M.-F., Blanchard, V., Sergeant, N., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03026.x · Cited by 51
Seo, J., Lee, K.-W., Kim, T., Baek, I., Im, J., & Han, P. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.035 · Cited by 51
Simons, L. J., Caprathe, B. W., Callahan, M. J., Graham, J. M., Kimura, T., Lai, Y., LeVine, H., Lipinski, W. J., Sakkab-Tan, A. T., Tasaki, Y., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.049 · Cited by 46
Self-citationPype, S., Moechars, D., Dillen, L., & Mercken, M. H. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01556.x · Cited by 44
Frackowiak, J., Miller, D. L., Potempska, A., Sukontasup, T., & Mazur‐Kolecka, B. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.6.685 · Cited by 49
Alterations in β-amyloid production and deposition in brain regions of two transgenic models
Lehman, E. J. H., Kulnane, L. S., & Lamb, B. T. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00153-7 · Cited by 55
Progressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model
Rönnbäck, A., Zhu, S., Dillner, K., Aoki, M., Lilius, L., Näslund, J., Winblad, B. G., & Graff, C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.021 · Cited by 47
Ito, K., Tatebe, T., Suzuki, K., Hirayama, T., Hayakawa, M., Kubo, H., Tomita, T., & Makino, M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.001 · Cited by 47
Sharman, M. J., Gyengési, E., Liang, H., Chatterjee, P., Karl, T., Li, Q.-X., Wenk, M. R., Halliwell, B. B., Martins, R. N., & Münch, G. W. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.11.026 · Cited by 46
Mehak, S. F., Shivakumar, A. B., Kumari, S., Muralidharan, B., & Gangadharan, G. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104628 · Cited by 45
Sex- and age-specific modulation of brain GABA levels in a mouse model of Alzheimer's disease
Roy, U., Stute, L., Höfling, C., Hartlage‐Rübsamen, M., Matysik, J., Roβner, S., & Alia, A. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.015 · Cited by 47
Helmond, Z. V., Miners, J. S., Kehoe, P. G., & Love, S. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00321.x · Cited by 44
Duffy, Á., Schaner, M. J., Wu, S. H., Staniszewski, A., Kumar, A. R., Arévalo, J. C., Arancio, O., Chao, M. V., & Scharfman, H. E. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.03.008 · Cited by 44
Liu, P., Reichl, J. H., Rao, E. R., McNellis, B. M., Huang, E. S., Hemmy, L. S., Forster, C. L., Kuskowski, M. A., Borchelt, D., Vassar, R. J., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-161027 · Cited by 41
Uses for humanised mouse models in precision medicine for neurodegenerative disease
Nair, R., Corrochano, S., Gasco, S., Tibbit, C., Thompson, D., Maduro, C., Ali, Z., Fratta, P., Acevedo‐Arozena, A., Cunningham, T. J., et al. (2019) · Mammalian Genome · doi:10.1007/s00335-019-09807-2 · Cited by 43
Law, A., Gauthier, S. G., & Quirion, R. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704179 · Cited by 43
Alteration of the Cerebral Zinc Pool in a Mouse Model of Alzheimer Disease
Lee, J., Cho, E., Seo, J.-W., Hwang, J. J., & Koh, J. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182417387 · Cited by 42
Sex Differences in Alzheimer’s Disease: Where Do We Stand?
Medeiros, A. D. M., & Silva, R. H. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180213 · Cited by 42
Marongiu, R. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00242 · Cited by 47
Molecular and Cellular Basis for Anti-Amyloid Therapy in Alzheimer Disease
Gandy, S., Martins, R. N., & Buxbaum, J. D. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200310000-00011 · Cited by 41
Porcellotti, S., Fanelli, F., Fracassi, A., Sepe, S., Cecconi, F., Bernardi, C., Cimini, A., Cerù, M. P., & Moreno, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/967203 · Cited by 41
Kulnane, L. S., & Lamb, B. T. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0446 · Cited by 63
Escrig, A., Canal, C., Sanchís, P., Fernández‐Gayol, O., Montilla, A., Comes, G., Molinero, A., Giralt, M., Giménez‐Llort, L., Becker‐Pauly, C., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.08.005 · Cited by 43
Association of ATP-Binding Cassette Transporter Variants With the Risk of Alzheimer‘s Disease
Cascorbi, I., Flüh, C., Remmler, C., Haenisch, S., Faltraco, F., Grumbt, M., Peters, M., Brenn, A., Thal, D. R., Warzok, R., et al. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.18 · Cited by 41
Peripheral Amyloid Levels Present Gender Differences Associated with Aging in AβPP/PS1 Mice
Ordóñez‐Gutiérrez, L., Antón, M., & Wandosell, F. G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141158 · Cited by 45
Chan, E. S., Shetty, M. S., Sajikumar, S., Chen, C., Soong, T. W., & Wong, B.-S. (2016) · Scientific Reports · doi:10.1038/srep26119 · Cited by 39
Harms, M. P., Kotyk, J. J., & Merchant, K. M. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.002 · Cited by 40
Granger, M. W., Franko, B., Taylor, M. W., Messier, C., George‐Hyslop, P. S., & Bennett, S. A. L. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150587 · Cited by 41
Haghani, A., Cacciottolo, M., Doty, K. R., D’Agostino, C., Thorwald, M. A., Safi, N., Levine, M. E., Sioutas, C., Town, T., Forman, H. J., et al. (2020) · eLife · doi:10.7554/elife.54822 · Cited by 40
Richetin, K., Petsophonsakul, P., Roybon, L., Guiard, B. P., & Rampon, C. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.025 · Cited by 37
Yanguas‐Casás, N., Torres‐Fuentes, C., Crespo‐Castrillo, A., Díaz-Pacheco, S., Healy, K., Stanton, C., Chowen, J. A., García‐Segura, L. M., Arévalo, M., Cryan, J. F., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105495 · Cited by 36
Lecordier, S., Pons, V., Rivest, S., & ElAli, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.813536 · Cited by 34
Hedberg, M. M., Clos, M. V., Ratia, M., Gonzalez, D., Lithner, C. U., Camps, P., Muñoz‐Torrero, D., Badı́a, A., Giménez‐Llort, L., & Nordberg, A. K. (2010) · Neurodegenerative Diseases · doi:10.1159/000287954 · Cited by 34
Progressing neurobiological strategies against proteostasis failure: Challenges in neurodegeneration
Amanullah, A., Upadhyay, A., Joshi, V., Mishra, R., Jana, N. R., & Mishra, A. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.005 · Cited by 34
Winkler, J. M., & Fox, H. S. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-51 · Cited by 32
The Role of Beta-Adrenergic Receptor Blockers in Alzheimer’s Disease
Lương, K. V. Q., & Nguyễn, L. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513488924 · Cited by 32
Higher levels of kallikrein‐8 in female brain may increase the risk for Alzheimer's disease
Keyvani, K., Münster, Y., Kurapati, N. K., Rubach, S., Schönborn, A., Kocakavuk, E., Karout, M., Hammesfahr, P., Wang, Y., Hermann, D. M., et al. (2018) · Brain Pathology · doi:10.1111/bpa.12599 · Cited by 32
Alzheimer’s Disease in Man and Transgenic Mice
Turner, R. S. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64026-6 · Cited by 31
Molecular basis for anti-amyloid therapy in the prevention and treatment of Alzheimer’s disease
Gandy, S. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00125-2 · Cited by 32
Modeling Alzheimer's disease and other proteopathies in vivo: Is seeding the key?
Walker, L. C., Bian, F., Callahan, M. J., Lipinski, W. J., Durham, R. A., & LeVine, H. (2002) · Amino Acids · doi:10.1007/s00726-001-0113-7 · Cited by 31
Self-citationReich, E. E., Montine, K. S., Gross, M. D., Roberts, L. J., Swift, L. L., Morrow, J. D., & Montine, T. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-16-05993.2001 · Cited by 35
Köhler, C., Ebert, U., Baumann, K., & Schröder, H. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.04.009 · Cited by 37
Walker, L., & Jucker, M. (2011) · Nature Neuroscience · doi:10.1038/nn.2853 · Cited by 34
Self-citationZiegler‐Waldkirch, S., Marksteiner, K., Stoll, J., d’Errico, P., Friesen, M., Eiler, D., Neudel, L., Sturn, V., Opper, I., Datta, M., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0549-6 · Cited by 30
Vidal, J., Verchere, C. B., Andrikopoulos, S., Wang, F., Hull, R. L., Cnop, M., Olin, K., LeBoeuf, R. C., O’Brien, K. D., Chait, A., et al. (2003) · Diabetologia · doi:10.1007/s00125-002-0984-5 · Cited by 30
Montgomery, K. S., Simmons, R. K., Edwards, G. A., Nicolle, M. M., Gluck, M. A., Myers, C. E., & Bizon, J. L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.003 · Cited by 30
Morales, R., Duran-Aniotz, C. A., Bravo-Alegria, J. B., Estrada, L. D., Shahnawaz, M., Hu, P., Kramm, C., Morales‐Scheihing, D., Urayama, A., & Soto, C. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01087-1 · Cited by 30
Chan, E. S., Chen, C., Cole, G. M., & Wong, B.-S. (2015) · Scientific Reports · doi:10.1038/srep13842 · Cited by 29
Oue, H., Miyamoto, Y., Koretake, K., Okada, S., Doi, K., Jung, C., Michikawa, M., & Akagawa, Y. (2014) · Gerodontology · doi:10.1111/ger.12153 · Cited by 29
Wang, B., Tanaka, K., Ji, B., Ono, M., Fang, Y., Ninomiya, Y., Maruyama, K., Nakajima, N. I., Begum, N. N. F., Higuchi, M., et al. (2013) · Journal of Radiation Research · doi:10.1093/jrr/rrt096 · Cited by 29
Repeat Mild Traumatic Brain Injury in Adolescent Rats Increases Subsequent β-Amyloid Pathogenesis
Grant, D. A., Serpa, R. O., Moattari, C. R., Brown, A., Greco, T., Prins, M. L., & Teng, E. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2017.5042 · Cited by 31
Choi, S. W., Gerencser, A. A., Ng, R., Flynn, J. M., Melov, S., Danielson, S. R., Gibson, B. W., Nicholls, D. G., Bredesen, D. E., & Brand, M. D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2414-12.2012 · Cited by 28
Long, Z., Zeng, Q., Wang, K., Sharma, A., & He, G. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw085 · Cited by 29
GRK5 deficiency exaggerates inflammatory changes in TgAPPsw mice
Li, L., Liu, J., & Suo, W. Z. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-24 · Cited by 26
Melnikova, T., Park, D., Becker, L. K., Lee, D., Cho, E., Sayyida, N., Tian, J., Bandeen‐Roche, K., Borchelt, D., & Savonenko, A. V. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.08.009 · Cited by 28
Tschiffely, A. E., Schuh, R. A., Prókai-Tátrai, K., Ottinger, M. A., & Prókai, L. (2017) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.11.015 · Cited by 27
Sutherland, G. T., Siebert, G. A., Kril, J. J., & Mellick, G. D. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110026 · Cited by 26
Datki, Z., Galik-Olah, Z., Mózes, E., Szegedi, V., Kálmán, J., Hunya, Á. G., Fülöp, L., Tamano, H., Takeda, A., Adlard, P. A., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0800-y · Cited by 25
Sex differences in a murine model of Cerebral Amyloid Angiopathy
Maniskas, M. E., Mack, A. F., Morales‐Scheihing, D., Finger, C. E., Zhu, L., Paulter, R., Urayama, A., McCullough, L. D., & Manwani, B. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100260 · Cited by 26
Steroid hormones: risk and resilience in women’s Alzheimer disease
Calvo, N., & Einstein, G. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1159435 · Cited by 27
Manso, Y., Carrasco, J., Comes, G., Adlard, P. A., Bush, A. I., & Hidalgo, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1045-y · Cited by 30
Martínez, M. F., Martín, X. E., Martín, E. B., Alcelay, L. G., Serrano, I. U., Busto, F. G., Álvarez-Álvarez, M., Salazar, A. M., Gandarias, R. B., Borda, S. I., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003200 · Cited by 25
Brain neprilysin activity and susceptibility to transgene-induced Alzheimer amyloidosis
Carter, T. L., Pedrini, S., Ghiso, J. A., Ehrlich, M. E., & Gandy, S. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.09.022 · Cited by 26
Bouter, C., Irwin, C., Franke, T. N., Beindorff, N., & Bouter, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.745064 · Cited by 27
Improving the predictive value of interventional animal models data
Zeiss, C. J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.015 · Cited by 25
Murakami, K., Yokoyama, S.-I., Murata, N., Ozawa, Y., Irie, K., Shirasawa, T., & Shimizu, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.101 · Cited by 25
Neurosteroids – From Basic Research to Clinical Perspectives
Frye, C. A. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00086-3 · Cited by 24
Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice
Ruiz‐Riquelme, A., Mao, A., Barghash, M. M., Lau, H. H. C., Stuart, E., Kovács, G. G., Nilsson, K. P. R., Fraser, P. E., Schmitt‐Ulms, G., & Watts, J. C. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01187-6 · Cited by 23
Dickson, D. W. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63202-6 · Cited by 23
Zhang, J., Zhou, W., Wang, L., & Zhang, X. (2017) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.02.008 · Cited by 24
Swaminathan, S. K., Zhou, A. L., Ahlschwede, K. M., Curran, G. L., Lowe, V. J., Li, L., & Kandimalla, K. K. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.265876 · Cited by 25
Characterization of the Brain β-Amyloid Isoform Pattern at Different Ages of Tg2576 Mice
Mustafiz, T., Portelius, E., Gustavsson, M. K., Hölttä, M., Zetterberg, H., Blennow, K., Nordberg, A. K., & Lithner, C. U. (2011) · Neurodegenerative Diseases · doi:10.1159/000323871 · Cited by 22
Xu, W., Lopez-Guzman, M., Schoen, C. B., Fitzgerald, S. M., Lauer, S. L., Nixon, R. A., Levy, E., & Wilson, D. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106431 · Cited by 21
Metadata
- Authors
- Callahan, M. J., Lipinski, W. J., Bian, F., Durham, R. A., Pack, A., & Walker, L. C.
- Affiliations
- Pfizer (United States) (US)
- Corresponding author
- Callahan, Michael J.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 158
- Issue
- 3
- Pages
- 1173-1177
- ISSN
- 0002-9440 (ISSN-L)
- PMC
- PMC1850367
- OpenAlex
- W2164192847
- Cited by
- 274
- References
- 30
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 8 · 2023: 5 · 2022: 8 · 2021: 14 · 2020: 10 · 2019: 14 · 2018: 9 · 2017: 10 · 2016: 9 · 2015: 17 · 2014: 15 · 2013: 16 · 2012: 10
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal Of Pathology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Tulane University
- York University
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid plaques, amyloid-beta, amyloid precursor protein, Tg2576 mice, sex differences, aging, Alzheimer's disease, amyloid deposition, hippocampus, neocortex, Aβ40, amyloid-beta 42
- MeSH terms
- Aging, Alzheimer Disease, Animals, Disease Models, Animal, Female, Hippocampus, Male, Mice, Transgenic, Peptide Fragments, Sex Factors, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Neocortex, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review